The Wall Street Journal reported that Anthropic's initial public offering could raise up to $100 billion

Overview Debates Related claims Topics

Anthropic established partnerships with six organizations alongside launching proprietary drug discovery initiatives

Mark Cuban Cost Plus Drug Company launched costplusdrugs.com on January 19, 2022, offering 111 generic medications

Mark Cuban Cost Plus Drug Company developed modular drug manufacturing units housed within tractor-trailer-sized pods

Mark Cuban Cost Plus Drug Company established teamcubancard.com as a discount card affiliated with approximately 17,000 pharmacies

Cost Plus Marketplace sells sterile injectables to clinics and hospitals at a transparent markup of 10% or 12% above cost

Anthropic's S-1 regulatory filing formally designated Google and OpenAI as Anthropic's two primary market competitors

Following the public disclosure of Anthropic's initial public offering filing, the Nasdaq index gained 2% and the Philadelphia Semiconductor Index rose by nearly 6%

Google secured deals to supply Tensor Processing Units to both OpenAI and Oracle

Weil, Gotshal & Manges was founded in 1931 and established its business on corporate restructuring and bankruptcies

Anthropic acquired Mithril Medicine, a one-person biotechnology company developing therapies for two rare forms of muscular dystrophy

As of October 2026, Mark Cuban Cost Plus Drug Company grew its catalog from 111 generic medications at launch to approximately 4,000 SKUs

Anthropic designated its mass physical book procurement and destructive digital scanning initiative as Project Panama

Merck voluntarily withdrew the anti-inflammatory medication Vioxx from the market after clinical data linked Vioxx to tens of thousands of fatal strokes

Weil, Gotshal & Manges represented clients in the corporate bankruptcies of Lehman Brothers, General Motors, and Enron

Mark Cuban Cost Plus Drug Company's Dallas manufacturing facility uses robotics and artificial intelligence within a 5,000-square-foot space

Dealmaker Michael Aiello stepped down from Weil, Gotshal & Manges in September 2026 after 20 years at the law firm

Anthropic entered into a partnership with Bristol Myers Squibb to apply artificial intelligence to early-stage clinical trial planning

As of October 2026, Anthropic has served as the primary external purchaser of Google's Tensor Processing Units

Mark Cuban Cost Plus Drug Company pays affiliated retail pharmacies a $12 fill fee per prescription under the Team Cuban Card program

Oracle reached an agreement to become the first major cloud provider besides Google to offer Google Tensor Processing Units to external clients